In this retrospective analysis we hypothesized that PSMA PET/CT and mpMRI are appropriate to localize the DIL (DIL-imaging) and that consequently, the dose parameters for DIL-imaging should correlate with the outcome in patients with PCa after EBRT. The gene discussed is FOLH1; the disease is posterior cortical atrophy.